Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dilated cardiomyopathy: a prospective cohort study

Fig. 1

The comparison of symptom severity, cardiac function, and myocardial tissue fibrosis between type 2 diabetes mellitus (T2DM) and non-T2DM in patients with dilated cardiomyopathy (DCM). DCM patients with T2DM had worse New York Heart Association (NYHA) class, lower biventricular function (A), and higher degree of myocardial fibrosis (B). LVEF, RVEF, native T1, and ECV values were adjusted for age, sex, body mass index, systolic blood pressure, atrial fibrillation, hypertension, and heart failure drugs. LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction; LGE, late gadolinium enhancement; ECV, extracellular volume fraction

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840